Evidence map›Paper›PMID 39033231›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2025

Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation.

Courtney Townsel, Burnley Truax, Margaret Quaid, Jonathan Covault, Dana C Dolinoy, Jaclyn M Goodrich

Abstract readMulticenter Study
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Neonatal Opioid Withdrawal Syndrome: 2 Years Later…Where Are We NOWS?The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Genetic and Epigenetic Approaches to Opioid Use Disorder.Expert reviews in molecular medicine · 2025
    Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Courtney TownselDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland, Baltimore, MD, USA. ctownsel@som.umaryland.edu.ORCID http://orcid.org/0000-0002-6650-9091
Burnley TruaxDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, USA.
Margaret QuaidDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0009-0001-6294-2429
Jonathan CovaultDepartment of Psychiatry, University of Connecticut, Farmington, CT, USA.
Dana C DolinoyDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, USA.
Jaclyn M GoodrichDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, USA.

Funding

Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
Environmental Epigenomics and Precision Environmental HealthR35ES031686 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2020 to 2026
$6.1M
NIEHS NIH HHS P30 ES017885NIEHS NIH HHS R35 ES031686
6 · The paper itself

Abstract

backgroundNeonatal opioid withdrawal syndrome (NOWS) is unpredictable. We assessed relationships between placental DNA methylation with in-utero opioid exposure and NOWS severity.

methodsSecondary analysis of a prospective multicenter cohort study of pregnancies on methadone or buprenorphine, ≥34 weeks, singleton, 18 or greater. Placental biopsies were collected. Placental DNA methylation levels of ABCG1, ABCG2, CYP19A1, and HSD11B2 were quantified via pyrosequencing following bisulfite conversion. CYP19A1 mRNA levels and umbilical cord drug levels were determined by RT-qPCR and LC-MS respectively. Severe NOWS was diagnosed through Finnegan scoring. P value < 0.05 was significant.

resultsThirty-eight dyads were included. Promoter region methylation for placental ABCB1 was lower in severe NOWS compared to non-severe NOWS (p = 0.04). Placental CYP19A1 methylation was inversely related to CYP19A1 mRNA levels and associated with umbilical cord norbuprenorphine levels (p < 0.01), but not umbilical cord methadone levels. DISCUSSION: Lower placental ABCB1 methylation was associated with severe NOWS. Higher placental CYP19A1 methylation correlated with higher umbilical cord norbuprenorphine levels.

Indexed as

DNA MethylationNeonatal Abstinence SyndromeOpioid-Related DisordersPlacentaPregnancy ComplicationsAdultAnalgesics, OpioidATP Binding Cassette Transporter, Subfamily BBuprenorphineFemaleFetal BloodHumansInfant, NewbornMethadoneOpiate Substitution TreatmentPregnancyABCB1 protein, humanAnalgesics, OpioidATP Binding Cassette Transporter, Subfamily BBuprenorphineMethadone

Identifiers

PMID39033231
PMCPMC11743817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.